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a b s t r a c t
We have reported previously that activation of the MyD88-signaling network rapidly induces the for-
mation of hybrid ubiquitin chains containing both Lys63-linked and Met1-linked ubiquitin (Ub) oligo-
mers, some of which are attached covalently to Interleukin Receptor Associated kinase 1. Here we show
that Lys63/Met1-Ub hybrids are also formed rapidly when the TNFR1/TRADD, TLR3/TRIF- and NOD1/
RIP2-signaling networks are activated, some of which are attached covalently to Receptor-Interacting
Protein 1 (TNFR1 pathway) or Receptor-Interacting Protein 2 (NOD1 pathway). These observations
suggest that the formation of Lys63/Met1-Ub hybrids are of general signiﬁcance for the regulation of
innate immune signaling systems, and their potential roles in vivo are discussed. We also report that
TNFa induces the attachment of Met1-linked Ub chains directly to TNF receptor 1, which do not seem to
be attached covalently to Lys63-linked or other types of ubiquitin chain.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The innate immune system is vital for defense against infection
by microbial pathogens, especially in young children [1]. In this
system, components of these microbes activate Pathogen Recog-
nition Receptors, such as TLRs and NOD proteins, triggering the
production of pro-inﬂammatory cytokines, such as IL-1 and TNFa,
which mount responses to combat the invading microbes.
Most TLRs, as well as the IL-1R, initiate signal transduction by
recruiting the adaptor protein MyD88, which is followed by the
binding of IRAK4 to MyD88, and then the association of other IRAK
family members with IRAK4 to form an oligomeric complex,
termed the Myddosome [2,3]. This leads within minutes to the
interaction of IRAKs 1 and 2with the E3 ubiquitin ligase TRAF6 [4,5]
and to the formation of Lys63-linked ubiquitin and Met1-linked
ubiquitin chains (K63-Ub, M1-Ub chains). The M1-Ub chains (also
called linear Ub chains) are formed by the E3 ligase LUBAC [6],
while K63-Ub chains can be formed by the action of TRAF6 in
combination with the E2-conjugating complex Ubc13-Uev1a (also
called UBE2N-UBE2V1) [7,8].
We found that the M1-Ub chains formed upon activation of the
MyD88 signaling network are attached covalently to preformed
K63-Ub chains, forming ubiquitin chains containing both types of
linkage, hereafter called K63/M1-Ub “hybrids” [9]. Some of the K63/
M1-Ub hybrids present in extracts prepared from IL-1 receptor-
expressing HEK293 cells (IL-1R cells) or human THP1 monocytes
were attached to IRAK1, but some were not anchored to any other
protein [9]. HOIP, the catalytic subunit of LUBAC, interacts with
K63-Ub oligomers speciﬁcally, but not with M1-Ub oligomers [9],
which may help to explain, at least in part, why K63-Ub oligomers
(and not ubiquitin monomers) are the preferred substrate for
LUBAC in the MyD88-dependent signaling network.
The formation of K63/M1-Ub hybrids provides a platform for the
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co-recruitment of two or more proteins that bind speciﬁcally to
either K63-Ub or M1-Ub oligomers, which include the two “mas-
ter” protein kinase complexes of the MyD88 signaling network, the
TAK1 and canonical IKK complexes. The TAB2 and TAB3 compo-
nents of TAK1 complexes [10] interact speciﬁcally with K63-Ub
oligomers [11,12] while NEMO, a regulatory component of the ca-
nonical IKK complex, binds to M1-Ub dimers with far higher af-
ﬁnity than it binds to K63-Ub dimers [13,14]. We have suggested
that the co-recruitment of these kinases to K63/M1-Ub hybridsmay
increase the efﬁciency with which TAK1 initiates activation of the
IKK complex [15].
Met1-linked ubiquitin chains are also formedwhen other innate
immune signaling networks are activated, such as the TNFa [16]
and NOD2 [17] signaling pathways and, similar to the MyD88
pathway, activation of TNFR1 or NOD2 induces the activation of
TAK1 and the canonical IKK complex. However, whether theM1-Ub
chains formed when other innate immune signaling pathways are
activated become attached covalently to K63-Ub and/or other types
of ubiquitin linkage, has not yet been investigated. Here we
demonstrate the rapid formation of K63/M1-Ub hybrids when
TNFR1, TLR3 and NOD1 signaling is activated, indicating that the
production of these molecules is a general feature of innate im-
mune signaling pathways.
2. Methods
2.1. Proteins
Proteins were of human origin and full length, unless stated
otherwise and were expressed in Escherichia coli and puriﬁed by
the Protein Production Teams of the MRC Protein Phosphorylation
and Ubiquitylation Unit (MRC-PPU) coordinated by James Hastie
and Axel Knebel. The proteins were:- lPPase (DU4170), GST-Otulin
(DU43487), AMSH-LP[264e436] (DU15780), vOTU (DU45351),
GST-OTUD3 (DU21323), His6-TRABID[245e697] (DU22468), GST-
Cezanne (DU20899), OTUB1 (DU19741) and Rat USP2[271e618]
(DU35832). The expression vectors and proteins generated with
their assigned [DU] numbers can be ordered from the reagent's
section of the MRC-PPU website (https://mrcppureagents.dundee.
ac.uk/). Murine TNFa was obtained from Peprotech (#315-01A)
and poly(I:C) from InvivoGen (tlrl-pic). Lys63-linked (K632-7) and
Met1-linked (M12-7) ubiquitin oligomeric standards were pur-
chased from Boston Biochem. The Halo-NEMO and Halo-TAB2
beads were prepared [9] and the NOD1 agonist KF1B synthesized as
described [18,19]. PNGase F was from New England Biolabs
(#P0704S).
2.2. Antibodies
An antibody recognizing IKKa phosphorylated at both Ser176
and Ser180 and IKKb phosphorylated at Ser177 and Ser181 (#2697)
and antibodies recognizing IRAK1 (#4504), K63-Ub linkages
(#5621) and GAPDH (#2118) were from Cell Signaling Technology.
A phospho-speciﬁc antibody recognizing JNK1 and JNK2 phos-
phorylated at Thr183 and Tyr185 (#44682) was obtained from
Invitrogen and an anti-RIP2 antibody from Abcam (ab8428). Anti-
ubiquitin was from Dako (#Z0458) and anti-RIP1 (#610459) from
BD Biosciences. An antibody recognizing M1-Ub chains speciﬁcally
[20] was generously provided by Vishva Dixit, Genentech, USA.
Anti-TNFR1 (sc-8436) was from Santa Cruz. Secondary antibodies
coupled to HRP were from Thermo Scientiﬁc.
2.3. Mice, cell culture, cell stimulation and cell lysis
Heterozygous knock-in mice expressing an E3-ligase inactive
mutant of HOIP (HOIP[C879S]) [9] were crossed to TNFR1 knock-
out mice. Macrophages were obtained by differentiation of foetal
livers from E13.5 embryos or bone marrow obtained from the fe-
mur and tibia of mice, as described [4]. Adherent BMDM were re-
plated into 12-well tissue culture plates (5  105 cells) or 10 cm
tissue culture grade plates (5  106 cells) using fresh culture me-
dium. After re-plating, liver macrophages or BMDM were stimu-
lated with 10 mg/ml poly(I:C) or RAW macrophages with
25 mM KF1B. Monocytes were puriﬁed from human peripheral
blood mononuclear cells and differentiated into macrophages as
described [21]. The human monocyte cell line THP1 was main-
tained in RPMImedium supplemented with 5% foetal bovine serum
(FBS), 2 mM L-glutamine and antibiotics (100 Units/ml penicillin,
0.1 mg/ml streptomycin) and cultured at 37 C in an 8% CO2 hu-
midiﬁed atmosphere. HeLa cells and MEFs were cultured in Dul-
becco's modiﬁed Eagle's medium (DMEM). THP-1 and HeLa cells
were stimulated with 10 ng/ml human TNFa or MEFs with 5 ng/ml
mouse IL-1a or 10 ng/ml mTNFa.
The cells were rinsed in ice-cold PBS and, unless stated other-
wise, were extracted in ice cold lysis buffer (50 mM Tris/HCl pH 7.5,
1mMEGTA,1mMEDTA,1% (v/v) Triton X-100,1mM sodium ortho-
vanadate, 50 mM NaF, 5 mM sodium pyrophosphate, 0.27 M su-
crose, 10 mM sodium 2-glycerophosphate, 1 mM phenyl-
methylsulphonyl ﬂuoride, 1 mM benzamidine, plus 100 mM
iodoacetamide to inactivate deubiquitylase activities. Cell lysates
were clariﬁed by centrifugation at 14,000 g for 30 min at 4 C and
the supernatants (cell extracts) were collected and their protein
concentrations determined by the Bradford procedure.
2.4. Capture of ubiquitin chains or ubiquitylated proteins
To capture ubiquitin chains, ubiquitylated proteins and other
proteins with which they interact, cell extracts (2e3 mg protein)
were incubated overnight at 4 C with either Halo-NEMO or Halo-
TAB2 beads (20 ml packed volume) as described [9,22]. The beads
were washed three times with 1 ml lysis buffer containing 500 mM
NaCl and once with 1 ml 10 mM Tris/HCl pH 8.0 and the captured
proteins were released by denaturation in SDS. To analyze ubiq-
uitylation events triggered by the NOD1 agonist KF1B, Halo-NEMO
beads were ﬁrst washed twice, each time for 3 min, with 50 mM
Tris/HCl pH 7.5 containing 0.1% (w/v) SDS and then three timeswith
50 mM Tris/HCl pH 7.5, 500 mM NaCl, 1% (v/v) Triton X100, and
once with 50 mM Tris/HCl pH 7.5. The brief wash with 0.1% (v/v)
SDS did not interfere with the capture of ubiquitin chains and
ubiquitylated proteins from the cell extracts but removed an im-
purity in the bacterially expressed Halo-NEMO preparation that
was recognized by anti-RIP2 and was of similar molecular mass to
RIP2.
2.5. Treatment with deubiquitylases, phosphatase and PNGase F
Proteins captured by Halo-NEMO beads were washed three
times with 1 ml of lysis buffer containing 0.5 M NaCl and once with
1 ml of 50 mM Tris/HCl pH 7.5, 50 mM NaCl, 2 mM DTT. The beads
were resuspended in 30 ml of 50 mM HEPES pH 7.5, 100 mM NaCl,
2 mM dithiothreitol (DTT), 1 mM MnCl2, 0.01% (w/v) Brij-35) with
lPPase (100 units/reaction) and incubated for 1 h at 37 C with or
without the deubiquitylases (DUBs) USP2 (1.0 mM), AMSH-LP
(0.2 mM), vOTU (0.1 mM), Otulin (1.0 mM), OTUB1 (2.0 mM),
Cezanne (5.0 mM), OTUD3 (2.0 mM) or TRABID (1.0 mM). To degly-
cosylate TNFR1, SDS and DTT were added to ﬁnal concentrations of
0.5% (w/v) and 40 mM, respectively, after DUB treatment and
heated for 10 min at 100 C. After cooling to 21 C, NP-40 and so-
dium phosphate buffer pH 7.5 were added to ﬁnal concentrations of
1% (v/v) and 50 mM, respectively, followed by incubation for 1 h at
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37 C with PNGase F (500 Units per reaction). Incubations were
terminated by denaturation in LDS and eluted proteins separated
from the beads using Spin-X columns and subjected to SDS-PAGE.
2.6. Immunoblotting
This was performed using the ECL system (GE Healthcare).
3. Results
3.1. TNFa induces the formation of K63/M1-Ub hybrids in human
THP1 monocytes
We stimulated THP1 cells with TNFa and captured the M1-Ub
chains and K63-Ub chains formed after 10 min on Halo-NEMO
beads or Halo-TAB2 beads (Fig. 1A). The immobilized Halo-NEMO
beads capture all the M1-Ub chains present in the cell extracts, as
shown by the failure of fresh Halo-NEMO beads to capture any
more M1-Ub chains from the supernatant obtained after the ﬁrst
Halo-NEMO pull down (Fig. 1A, top panel compare lanes 2 and 6).
The Halo-NEMO beads also captured a small proportion of the K63-
Ub chains present in the cell extracts (Fig. 1A, bottom panel lanes 1
and 2), which should include any K63-Ub chains attached cova-
lently to M1-Ub chains as K63/M1-Ub hybrids. In contrast, Halo-
TAB2 beads, which bind to K63-Ub chains speciﬁcally and do not
interact directly withM1-Ub chains [11,12], captured all the K63-Ub
chains present in the cell extracts (Fig. 1A, bottom panel compare
lanes 3 and 4 with 9 and 10). Interestingly, the Halo-TAB2 beads
also captured all the M1-Ub chains present in the cell extracts
(Fig. 1A, compare lanes 4 and 12). This is consistent with the notion
that the M1-Ub chains may be attached covalently to K63-Ub
chains.
To investigate whether TNFa had induced the formation of K63/
M1-Ub hybrids, we studied the formation of the small ubiquitin
oligomers that were generated when Halo-NEMO beads were
incubated with the AMSH-LP), a DUB that cleaves K63-Ub chains
speciﬁcally [23] or with Otulin, a DUB that only cleaves M1-Ub
chains [24]. These DUBs cleaved all the large K63-Ub chains or
Fig. 1. TNFa-stimulation of human THP1 monocytes induces the formation of K63/M1-Ub hybrids. (A) THP-1 monocytes were stimulated for 10 min with 10 ng/ml hTNFa and
ubiquitin chains were captured from 2 mg of cell extract protein with Halo-NEMO or Halo-TAB2 [ﬁrst pulldown (1.PD)]. The supernatants from the ﬁrst PD were subjected to a
second PD (2.PD) using either Halo-NEMO or Halo-TAB2 as indicated. Captured Ub chains were identiﬁed by immunoblotting with antibodies that recognize K63-Ub or M1-Ub
chains speciﬁcally. (B) As in (A) except that, after the Halo-NEMO pull-down, samples were treated for 1 h with phage lPPase (100 units) in the absence (control) or presence
of the deubiquitylases AMSH-LP (0.2 mM), Otulin (1.0 mM), AMSH-LP plus Otulin, or USP2 (1.0 mM). The samples were subjected to SDS/PAGE and immunoblotted with antibodies
recognizing K63-Ub or M1-Ub chains. (C, D) As in B, except that an anti-Ub antibody recognizing M1-Ub and K63-Ub linkages equally well was used for immunoblotting to detect
the small Ub oligomers released by treatment with DUBs. In addition, K63-Ub oligomeric markers (5 ng/lane) and M1-Ub oligomeric markers (12 ng/lane) were included in Lanes 4
and 9 in C and lanes 1 and 6 in D to identify the small Ub oligomers formed after treatment with AMSH-LP and/or Otulin.
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M1-Ub chains captured by Halo-NEMO beads (Fig. 1B). Similar to
our previous ﬁndings in the IL-1 signaling network [9], we found
that the complete hydrolysis of K63-Ub chains induced the
appearance of small Ub oligomers containing 4e7 ubiquitins, which
co-migrated with M1-Ub standard oligomers (Fig. 1C, compare
lanes 7e9 with lanes 5 and 6) and could be hydrolysed by Otulin
(Fig. 1C, compare Lanes 10 and 11 with lanes 7 and 8). These ﬁnd-
ings establish that TNFa stimulates the formation of K63/M1-Ub
hybrids within minutes in THP1 monocytes.
Incubation of the Halo-NEMO beads with AMSH-LP also gener-
ated small ubiquitin oligomers containing 2, 3 and 4 ubiquitins
(indicated by stars) but their electrophoretic mobilities differed
from either K63-Ub or M1-Ub oligomers of the same chain length
(Fig. 1C, lanes 7 and 8). These Ub oligomers were resistant to hy-
drolysis by both AMSH-LP or Otulin but could be cleaved by USP2
(Fig. 1C, lanes 10e13). These small Ub-oligomers were generated in
similar amounts by incubation with AMSH-LP plus Otulin, whether
or not the cells had been stimulated with TNFa (Fig. 1D, lanes 3 and
5). They are presumably derived from a hybrid ubiquitin chain
comprising K63-Ub and another type of ubiquitin linkage, which is
present in the extracts of cells not stimulated with TNFa. Why these
hybrid ubiquitin chains are captured by Halo-NEMO is unclear.
The hydrolysis of M1-Ub chains also led consistently to the
formation of small Ub oligomers containing 4e6 ubiquitins that co-
migrated with K63-Ub standard oligomers during SDS-PAGE and
were hydrolysed by AMSH-LP (Fig. 1C compare lanes 4e6 with
lanes 10 and 11). However, they were difﬁcult to detect by immu-
noblotting, presumably due to the paucity of these K63-Ub
oligomers.
3.2. TNFa-induces the formation of hybrid ubiquitin chains
attached to RIP1
TNFa-stimulation induces the recruitment of the adaptor pro-
tein TRADD to TNFR1, which is followed by the recruitment of a
signaling complex containing TRAF2, the E3 ubiquitin ligases cIAP1)
and cIAP2, Receptor-Interacting Protein 1 (RIP1) and LUBAC [25].
The cIAP1 and cIAP2 catalyze the ubiquitylation of RIP1, and the
ubiquitin chains attached to RIP1 are thought to bind to TAB2 and
TAB3 and induce activation of the TAK1 complex. TAK1 can then
activate the canonical IKK complex and MAP kinase cascades
[11,26e28].
Following TNFa-stimulation, only a minor proportion of the
RIP1 in THP1 monocytes (and other cells) undergoes ubiquitylation
[22]. We found that Halo-NEMO beads captured the ubiquitylated
species of RIP1 (Fig. 2A). Incubation with Otulin consistently
reduced the size of the ubiquitin chains attached to RIP1 in THP1
monocytes, but without generating any mono-ubiquitylated or
unmodiﬁed RIP1 (Fig. 2A, compare lanes 5 and 6). This ﬁnding
demonstrated that not only were M1-Ub linkages present in the
ubiquitin chains attached to RIP1, but also that they were attached
covalently to another type of ubiquitin linkage(s) that was itself
attached to RIP1. Similar observations were made in extracts of
primary human macrophages (Fig. 2B). However, treatment with
Otulin did not detectably alter the electrophoretic mobility of the
ubiquitylated-RIP1 captured by Halo-NEMO beads from the ex-
tracts of TNFa-stimulated HeLa cells or immortalized MEFs (Fig. 2A,
lanes 1e4). This may be due to the small number of M1-Ub linkages
formed when these cells are stimulated with TNF, as compared to
THP1 monocytes (Fig. 2A, bottom panel). Alternatively, or in addi-
tion, the effect of Otulin may be obscured because RIP1 molecules
lacking M1-Ub linkages contain more ubiquitin linkages of other
types. Consistent with this interpretation, RIP1 immunoprecipi-
tated from the extracts of TNFa-stimulated MEFs was recently re-
ported to contain low levels of M1-Ub together with much larger
quantities of K63-Ub chains [29].
We also incubated the Halo-NEMO beads with AMSH-LP to
cleave all the attached K63-Ub chains (Fig. 1B). Treatment with
AMSH-LP plus Otulin generatedmuch smaller ubiquitylated species
of RIP1 than those generated by incubation with Otulin alone
(Fig. 2C, compare lanes 6 and 7 with 10 and 11), indicating that
some of the ubiquitin molecules attached to RIP1 were linked via
Lys63 of ubiquitin. However, even after complete hydrolysis of the
K63-Ub and M1-Ub linkages with Otulin plus AMSH-LP, RIP1 still
migrated as a ladder of bands containing a number of ubiquitin
molecules, which could be hydrolysed by the non-speciﬁc DUB
USP2. These ubiquitylated species could represent multi-mono-
ubiquitylated forms of RIP1 in which mono-ubiquitin is attached
covalently to two, three or more lysine residues in the protein, and/
or smaller ubiquitin oligomers of a distinct linkage type. Consistent
with the latter possibility, the ubiquitin chains attached to the
endogenous RIP1 after TNFa-stimulation have been reported to
contain K11-Ub and K48-Ub linkages, as well as K63-Ub linkages
[30].
3.3. Met1-linked ubiquitin chains are attached directly to TNFR1 in
THP1 cells
Interestingly, we found that Halo-NEMO beads captured high
molecular mass forms of TNFR1 from the extracts of TNFa-stimu-
lated THP1 monocytes, but not from the extracts of unstimulated
cells (Fig. 3A, lanes 1e4). Treatment of the Halo-NEMO beads with
USP2 converted these high molecular mass forms to much faster
migrating species, indicating that TNFa had triggered the ubiq-
uitylation of TNFR1. The electrophoretic mobility of TNFR1 was
increased further by incubation of the Halo-NEMO beads with USP2
plus the PNGase F, which hydrolyses carbohydrate moieties
attached to asparagine residues on TNFR1 [31]. PNGase F and
phagel protein phosphatase (lPPase) were therefore included in all
subsequent experiments to remove covalently bound carbohydrate
and phosphate from TNFR1, which might otherwise complicate
interpretation of the results.
We found that treatmentwith Otulin largely converted TNFR1 to
a discrete ladder of bands that corresponded to mono-, di- and tri-
ubiquitylated species, together with smaller amounts of diffuse
species of higher molecular mass (Fig. 3B). The latter were reduced
by further treatment with AMSH-LP to hydrolyse K63-Ub linkages
and almost completely by treatment with AMSH-LP plus Cezanne, a
DUB that cleaves K11-Ub linkages relatively speciﬁcally. The further
addition of OTUB1 (which hydrolyses K48-Ub linkages speciﬁcally),
OTUD3 (which hydrolyses many ubiquitin linkages including K6-
Ub chains) and TRABID (which hydrolyses K29-Ub and K33-Ub
linkages) had little effect [23,32]. The simplest interpretation of
these results is that the mono-, di- and tri-ubiquitylated species
generated by Otulin are multi-mono-ubiquitylated forms of TNFR1,
implying that, in contrast to RIP1, M1-Ub chains are attached
directly to the mono-ubiquitylated TNFR1 and not indirectly by
attachment to another type of ubiquitin chain. In addition, lesser
amounts of K11-Ub and K63-Ub oligomers also appear to be
attached to the TNFR1.
3.4. Activation of the TRIF-dependent signaling network induces the
formation of K63/M1-Ub hybrids
dsRNA formed during viral replication activates TLR3, which
recruits TRIF. This initiates signal transduction pathways, one of
which leads to the ubiquitylation of RIP1 and activation of the ca-
nonical IKK complex. In the present study we stimulated murine
BMDM with the synthetic dsRNA mimetic poly(I:C) and captured
the ubiquitin chains and ubiquitylated proteins present in the cell
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Fig. 2. TNFa induces the formation of hybrid ubiquitin chains containing M1-Ub linkages. (A) HeLa cells, MEFs and THP1 monocytes were stimulated for 10 min with TNFa and
ubiquitylated proteins captured from 2 mg cell extract protein and incubated with or without 1.0 mM Otulin as in Fig. 1. The samples were subjected to SDS/PAGE and immu-
noblotted with an antibody that recognizes all forms of RIP1. (B) As in A, except that human primary macrophages were stimulated with TNFa. (C) As in Fig. 1B, except that the
samples were immunoblotted with the RIP1 antibody.
Fig. 3. TNFa-stimulated attachment of M1-Ub chains to TNF Receptor 1. (A) THP-1 monocytes were stimulated for 10 minwith 10 ng/ml TNFa and ubiquitin chains were captured
from 2.5 mg of cell extract protein on Halo-NEMO beads. Samples were treated for 1 h with l-PPase in the presence or absence of USP2 (1 mM) and/or PNGase F (500 Units). The
TNFR1 protein was identiﬁed by immunoblotting. (B) As in A except that ubiquitylated forms of TNFR1 captured on immobilized Halo-NEMO were treated with l-PPase (100 Units),
PNGase F (500 Units) and the DUBs Otulin (1 mM), OTUB1 (2 mM), AMSH-LP (0.25 mM), Cezanne (5 mM), OTUD3 (2 mM), or TRABID (1 mM) as indicated. The samples were subjected to
SDS-PAGE and immunoblotted with an antibody raised against TNFR1.
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extracts on Halo-NEMO beads. Stimulation with poly(I:C) induced
the formation of M1-Ub chains, the ubiquitylation of RIP1 and the
activation of the canonical IKK complex and JNK1/JNK2 that were
maximal between 60 and 90 min (Fig. 4A). Poly(I:C) also induced
the formation of K63-Ub chains after 60 min (Fig. 4B). Subsequent
experiments were therefore carried out after 60 min stimulation.
To investigate whether poly(I:C) had stimulated the formation
of K63/M1-Ub hybrids, we again studied the formation of the small
ubiquitin oligomers that were generated when Halo-NEMO beads
were incubated with AMSH-LP to cleave K63-Ub chains or with
Otulin to cleave M1-Ub chains (Fig. 4B, top two panels). The
complete hydrolysis of M1-Ub chains reduced the size and amount
of the largest K63-Ub chains (Fig. 4B top panel), and induced the
appearance of small Ub oligomers containing 2e7 ubiquitins that
co-migrated precisely with K63-Ub oligomeric standards (Fig. 4B
bottom panel, compare lanes 6 and 7 with lane 5) and which could
be cleaved by AMSH-LP (Fig. 4B, lanes 11 and 12). Conversely, the
complete hydrolysis of K63-Ub chains reduced the size and amount
of the largest M1-Ub chains (Fig. 4B middle panel), and increased
the amount of the small Ub oligomers that co-migrated with M1-
Ub oligomeric standards (Fig. 4B bottom panel, compare lanes 8
and 9 with 10) and could be cleaved by Otulin (Fig. 4B, lanes 11 and
Fig. 4. Poly(I:C) induces K63/M1-Ub hybrid chain formation in BMDM. (A) BMDM were stimulated with 10 mg/ml poly(I:C) for the times indicated and ubiquitin chains were
captured from 2 mg of cell extract protein with Halo-NEMO beads. The captured M1-Ub chains and ubiquitylated RIP1 were identiﬁed by immunoblotting. Aliquots of the cell
extract (20 mg protein) were subjected to SDS-PAGE and immunoblotting with antibodies that recognize the active phosphorylated forms of IKKa, IKKb, JNK1 and JNK2, and with
GAPDH as a loading control. (B) Similar to (A) except that, after the Halo-NEMO pull-down, samples were treated for 1 h with l-PPase (100 units) in the absence () or presence (þ)
of Otulin (1.0 mM) and/or AMSH-LP (0.2 mM). The samples were subjected to SDS/PAGE and proteins of >65 kDa immunoblotted for K63-Ub and M1-Ub chains. Proteins <50 kDa
were immunoblotted with an antibody that recognizes all forms of ubiquitin to detect the small Ub oligomers released by treatment with DUBs. M1-Ub oligomeric standard marker
proteins (12 ng - lanes 4 and 10) and K63-Ub oligomeric standards (5 ng - lane 5) were included to identify the small Ub oligomers formed after treatment with AMSH-LP or Otulin.
(C) Similar to B except that, after incubation with Otulin and/or AMSH-LP, the gels were immunoblotted with a RIP1 antibody, as well as with antibodies that recognize M1-Ub and
K63-Ub chains. (D) Similar to B, except that the large and small M1-Ub oligomers were detected by immunoblotting before and after treatment with the deubiquitylases AMSH-LP
and/or vOTU (0.1 mM).
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12). These experiments demonstrate that activation of the
poly(I:C)/TLR3/TRIF pathway triggers the formation of K63/M1-Ub
hybrids.
Importantly, the bulk of theM1-Ub chains formed in response to
poly(I:C) and captured from the cell extracts on Halo-NEMO beads
(>200 kDa) were larger than the ubiquitin chains attached to RIP1
(Fig. 4C, top and bottom panel), implying that most of the M1-Ub
chains formed in response to poly(I:C) were not attached cova-
lently to RIP1. Consistent with this inference, most of the ubiquitin
chains attached to RIP1 disappeared upon incubation with AMSH-
LP, while treatment with Otulin had relatively little effect (Fig. 4C,
top panel). These observations suggest that most of the ubiquitin
chains attached to RIP1 are linked via Lys63, although a small
number of M1-Ub linkages may also be present.
Interestingly, the high molecular mass M1-Ub chains still
remaining after incubation with AMSH-LP disappeared when the
Halo-NEMO beads were incubated with AMSH-LP plus vOTU, or
with vOTU alone (Fig. 4D, middle panel). vOTU is a virally-encoded
DUB, which hydrolyses all Ub-linkage types, except for M1-Ub and
K29-Ub linkages [23]. Treatment with AMSH plus vOTU increased
the formation of the small M1-Ub oligomers compared to AMSH-LP
alone (Fig. 4D, bottom panel), suggesting that the large M1-Ub
chains still present after treatment with AMSH-LP may comprise
hybrid ubiquitin chains containing M1-Ub and another Ub link-
age(s) type distinct from K63-Ub chains. However, it cannot be
excluded that these M1-Ub oligomers were attached directly to a
mono-ubiquitylated protein(s), since vOTU also cleaves the ﬁrst
ubiquitin moiety attached to proteins.
3.5. Activation of NOD1 signaling induces the formation of K63/M1-
Ub hybrids
NOD1 and NOD2 are cytosolic receptors that sense the presence
of intracellular bacteria. Upon activation by peptides derived from
bacterial peptidoglycans, the NOD1/2 receptors interact with RIP2
and XIAP, another member of the IAP family of E3 ubiquitin ligases
that is encoded by an X chromosome-linked gene. This leads to the
ubiquitylation of RIP2 [33], and the activation of TAK1 [34] and NF-
kB [35]. Here, we stimulated the RAW264.7 macrophage-like cell
line with the NOD1 agonist KF1B (Fig. 5A) and captured the ubiq-
uitylated forms of RIP2, M1-Ub chains and associated K63-Ub
chains from the cell extracts on Halo-NEMO beads (Fig. 5B). Incu-
bation with Otulin decreased the size of the ubiquitin chains
attached to RIP2, but without causing any conversion to mono-
ubiquitylated or deubiquitylated species. (Fig. 5B, compare lanes
2e7). These experiments show that the ubiquitylated RIP2 contains
M1-Ub linkages that are not attached directly to a lysine residue on
RIP2, but are attached to RIP2 indirectly via another type of ubiq-
uitin linkage(s). Similar observations have been made previously in
RAW macrophages after stimulation with the NOD2 activator
muramyl dipeptide [17]. Incubation of the Halo-NEMO beads with
Otulin plus AMSH-LP largely converted RIP2 to a mixture of mono-
ubiquitylated, diubiquitylated and tri-ubiquitylated species (Fig. 5B,
lanes 8 and 9) that may be multi-monoubiquitylated forms of RIP2,
or RIP2 containing a further type of Ub linkage. Taken together,
these experiments indicate that hybrid ubiquitin chains containing
both M1-Ub and K63-Ub linkages are attached to RIP2 when the
NOD1 receptor is activated.
3.6. The role of Met1-linked ubiquitin chains in activating the
canonical IKK complex in different innate immune signaling
pathways
HOIP is the catalytic component of LUBAC. We have generated
MEFs from embryos that express the catalytically inactive HOIP
[C879S] mutant instead of wild type HOIP, and showed that they do
not form any M1-Ub chains in response to IL-1a [9]. Here, we show
that MEFs from the HOIP[C879S] embryos also failed to produce
M1-Ub chains upon stimulation with TNFa (Fig. 6A). Similarly,
macrophages derived from the foetal livers of these mice did not
produce any M1-Ub chains after stimulationwith poly(I:C) (Fig. 6B)
or LPS (Fig. 6C). These results demonstrate that HOIP, is the only E3
Fig. 5. KF1B induces the NOD1-dependent formation of hybrid ubiquitin chains attached to RIP2 that contain K63 and M1-Ub linkages. (A) The structure of KF1B. (B) RAW
macrophages were stimulated for 30 min with 25 mM KF1B and ubiquitin chains captured from 2 mg of cell extract protein with SDS-washed Halo-NEMO beads (see Methods). The
samples were treated for 1 h with lPPase (100 units) plus AMSH-LP (0.05 mM) and/or Otulin, or USP2 (1.0 mM). The samples were subjected to SDS/PAGE and immunoblotted with
antibodies that recognize RIP2, M1-Ub chains or K63-Ub chains.
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ligase generating M1-Ub chains when the IL-1R, TNFR1, TLR3 and
TLR4 receptors are activated.
We have also shown that the IL-1a-dependent activation of IKKa
and IKKb is greatly reduced in MEFs from HOIP[C879S] embryos, as
shown by the drastic decrease in the IL-1a-dependent phosphor-
ylation of the activation loops of these protein kinases ([9] and see
also Fig. 6D). In contrast, the TNFa-dependent activation of the IKKs
was only reduced by about 50% in MEFs from the HOIP[C879S]
embryos (Fig. 6D). The poly(I:C)-stimulated (Fig. 6B) or LPS-
stimulated (Fig. 6C) phosphorylation of the canonical IKK com-
plexwere also reduced by about 50% inmacrophages from the HOIP
[C879S] embryos.
4. Discussion
In this paper, we show that hybrid ubiquitin chains containing
M1-Ub and K63-Ub linkages are produced rapidlywhen the TNFR1-
TRADD, TLR3-TRIF and NOD1-RIP2 signaling pathways are acti-
vated. In conjunction with our earlier studies on the IL-1R/TLR-
MyD88 signaling network [9] and other studies on NOD2
signaling [17], these observations demonstrate that the rapid for-
mation of hybrid ubiquitin chains containing M1-Ub linkages is a
general feature of innate immune signaling systems. All these
networks trigger the activation of the TAK1 and canonical IKK
complexes, so that one role of these hybrid chains may be to co-
recruit these kinase complexes and so facilitate the TAK1-
dependent activation of the IKKs, as mentioned in the Introduction.
However, the K63/M1-hybrids are likely to serve several other
functions. For example, A20-binding inhibitor of NF-kB 1 (ABIN1),
which possesses a similar ubiquitin-binding domain to NEMO, re-
stricts the activation of TAK1 and the canonical IKK complex by
binding to the K63/M1-Ub hybrids. As a consequence, TAK1 and IKK
become hyper-activated, and pro-inﬂammatory cytokines are
overproduced, when the TLR-MyD88 network and NOD2 signaling
network are activated in myeloid cells from knock-in mice
expressing the ubiquitin-binding-defective ABIN1[D485N] mutant.
These mice develop a disease that closely resembles Type III and
Type IV lupus in humans, termed lupus nephritis, and this can be
Fig. 6. M1-Ub chain formation and activation of the canonical IKK complex in cells from knock-in mice expressing an E3 ligase-inactive mutant of HOIP. (A) MEFs expressing
either wild-type (WT) HOIP or the E3 ligase-inactive HOIP[C879S] mutant ([C879S]) were stimulated with either 5 ng/ml IL-1a or 10 ng/ml mTNFa for the times indicated. M1-Ub
chains captured from the cell extracts with Halo-NEMO were identiﬁed by immunoblotting with a speciﬁc antibody. (B, C) Macrophages derived from the foetal livers of WT or HOIP
[C879S] knock-in mice were stimulated with poly(I:C) (B) or LPS (C) for the times indicated. Cell extract (20 mg protein) was subjected to SDS-PAGE and immunoblotted with
antibodies that recognize M1-Ub chains (top panel), the activated forms of IKKa, IKKb, JNK1 and JNK2, the three components of LUBAC (HOIP, HOIL-1 and Sharpin) and GAPDH as a
loading control. (D) As in A except that the extracts (20 mg protein) were immunoblotted with antibodies that recognize the active phosphorylated form of IKKa and IKKb and for
GAPDH as a loading control.
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prevented by crossing the ABIN1[D485N]mice toMyD88 knock-out
mice [36]. Moreover, the ABIN1-interacting protein A20, which also
restricts the activation of TAK1 and the canonical IKK complex,
contains seven zinc ﬁngers at its C-terminus, two of which are re-
ported to bind speciﬁcally to K63-Ub linkages and M1-Ub linkages,
respectively [37e40]. Thus ternary complexes formed between
ABIN1, A20 and K63/M1-Ub hybrids have critical roles in prevent-
ing the overproduction of inﬂammatory mediators. It has also been
reported that the covalent attachment of M1-Ub oligomers to K63-
Ub oligomers suppresses the rate at which K63-Ub oligomers are
hydrolysed in vitro by the deubiquitylase activity of A20, which is
located near the N-terminus of the protein [29]. Thus hybrid
ubiquitin chains may affect the rates at which K63-Ub and M1-Ub
chains are deubiquitylated and so control the duration of the
innate immune response.
The TNFa-stimulated activation of the canonical IKK complex
was only reduced by about 50% inMEFs fromHOIP[C879S] embryos
that cannot produce any M1-Ub linkages. This is similar to obser-
vations made previously in human and mouse ﬁbroblasts lacking
expression of one or more components of LUBAC [41,42]. A similar
reduction in IKK activation was observed when liver macrophages
from HOIP[C879S] mice were stimulated with poly(I:C) (Fig. 6B) or
LPS (Fig. 6C) to activate the TLR3-TRIF and TLR4-TRIF/MyD88
signaling network. This contrasts with the more drastic reduction
in IKK activation observed when MEFs from HOIP[C879S] embryos
were stimulated with IL-1a ([9] and see also Fig. 6D). The reason
why the formation of M1-Ub chains appears to be more critical for
IL-1a-dependent IKK activation than TNFR1-dependent or TLR3-
dependent IKK activation is unclear. It might be explained by dif-
ferences in the topology of the K63/M1-Ub hybrids that are formed
in response to the different stimuli and/or by the presence of a
further type of ubiquitin linkage in the K63/M1-Ub-containing
hybrid molecules that are formed in response to TNFa or poly(I:C).
The only protein detected in this study in which the M1-Ub
chains did not seem to be attached covalently to another type of
ubiquitin linkage was TNFR1, most of the M1-Ub chains apparently
being linked directly to the ﬁrst ubiquitinmoiety attached toTNFR1.
While our studies were in progress, two other laboratories also
reported that M1-Ub chains were attached covalently to the TNFR1
[29,43], although the mechanism of attachment was not investi-
gated. Since MEFs from HOIP-deﬁcient embryos are hypersensitive
to TNFa-induced cell death, these investigators suggested that the
ubiquitylation of TNFR1 may function mainly to regulate cell death.
In contrast, the TNFa-stimulated formation of hybrid ubiquitin
chains containing M1-Ub, K63-Ub and other Ub-linkage types that
are attached to RIP1 may function to activate the TAK1 and ca-
nonical IKK complexes, which inhibits TNFa-induced apoptosis by
activating NF-kB.
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